| 000 | 01902 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513185842.0 | ||
| 264 | 0 | _c19990924 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/s0169-5002(99)00015-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIwai, N | |
| 245 | 0 | 0 |
_aAutocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cMar 1999 |
||
| 300 |
_a209-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aAutocrine Communication _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xgenetics |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCinnamates |
| 650 | 0 | 4 |
_aCulture Media, Conditioned _xmetabolism |
| 650 | 0 | 4 |
_aDitiocarb _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aFatty Acids, Monounsaturated _xpharmacology |
| 650 | 0 | 4 |
_aGrowth Inhibitors _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHygromycin B _xanalogs & derivatives |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMultienzyme Complexes |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xgenetics |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 | _aTumor Stem Cell Assay |
| 700 | 1 | _aMartÃnez, A | |
| 700 | 1 | _aMiller, M J | |
| 700 | 1 | _aVos, M | |
| 700 | 1 | _aMulshine, J L | |
| 700 | 1 | _aTreston, A M | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 23 _gno. 3 _gp. 209-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0169-5002(99)00015-x _zAvailable from publisher's website |
| 999 |
_c10371277 _d10371277 |
||